Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
A. Fosam, S. C. B. R. Nakandakari, Y. Ohashi, H. Bai, J. O'Connell, A. Raines, I. Chavez Miranda, A. Dardik, C. Allen, R. J. Perry
This paper introduces a comprehensive protocol for implementing blood flow restriction exercise in awake rats following ACL-R to study its effects on muscle growth and atrophy.
bioRxiv · Mar 27, 2024Animal Behavior & Cognition
T. S. Faniyan, X. Zhang, D. A. Morgan, J. Robles, S. Bathina, R. J. Perry, P. S. Brookes, K. Rahmouni, K. H. Chhabra
This study shows that afferent renal nerves promote compensatory glucose production in response to glycosuria by activating the hypothalamic-pituitary-adrenal axis in mice.
bioRxiv · Sep 1, 2023Physiology
Z. Li, X. Zhang, W. Zhu, Q. Xu, C. Yu, Q. Zhao, S. Siebel, C. Zhang, B. G. Costa Lima, X. Li, K. Israni-Winger, A. R. Nasiri, M. J. Caplan, R. B. Chang, A. Wang, , R. J. Perry
This study identifies GDF15 as a new hypoglycemia counterregulatory hormone, showing it increases hepatic gluconeogenesis through renal release and beta-adrenergic receptor-2 signaling.
bioRxiv · Jun 22, 2023 · PreprintPhysiology
Z. Li, X. Zhang, W. Zhu, C. Zhang, K. Sadak, A. A. Halberstam, J. R. Brown, C. J. Perry, A. Bunn, D. A. Braun, A. Adeniran, S. Lee, A. Wang, R. J. Perry
This study identifies FGF-21's role in promoting renal gluconeogenesis through a liver-brain-kidney axis, linking it to accelerated renal cell carcinoma progression and suggesting Adrb2 blockade as a potential therapy.
bioRxiv · Apr 12, 2023 · PreprintPhysiology
A. Hemalatha, Z. Li, K. Tai, D. G. Gonzalez, E. Lathrop, D. Gil, C. Matte-Martone, S. Ganesan, S. Yun, L. E. Gonzalez, M. C. Skala, R. J. Perry, V. Greco
The paper investigates metabolic adaptations in winner and loser oncogenic mutant stem cells in skin epidermis, revealing distinct metabolic strategies that drive cell competition outcomes.
bioRxiv · Nov 21, 2022 · PreprintCancer Biology
B. P. Leitner, W. D. Lee, W. Zhu, X. Zhang, R. C. Gaspar, Z. Li, J. D. Rabinowitz, R. J. Perry
This study identifies tissue-specific metabolic reprogramming in sepsis, showing that mitochondrial adaptations in vital organs, not global dysfunction, underlie sepsis tolerance.
bioRxiv · Oct 8, 2022 · PreprintPhysiology
N. D. Akingbesote, B. P. Leitner, D. G. Jovin, R. Desrouleaux, W. Zhu, Z. Li, M. N. Pollak, R. J. Perry
The paper uses gene expression and metabolic flux analysis to show that metabolic scaling occurs in multiple pathways across species, not just oxygen consumption.
bioRxiv · Mar 2, 2022Physiology
N. D. Akingbesote, A. Norman, W. Zhu, A. A. Halberstam, X. Zhang, J. R. Foldi, M. B. Lustberg, R. J. Perry
This study combines dapagliflozin with paclitaxel chemotherapy in mice, showing enhanced tumor response in some breast cancers based on insulin signaling mutation location.
bioRxiv · Dec 15, 2021Cancer Biology
B. P. Leitner, S. Ospanova, A. Beisenbayeva, K. B. Givechian, K. Politi, R. J. Perry
This study compares immunometabolic features of lung adenocarcinoma and squamous cell carcinoma using multimodal data, finding distinct metabolic and immune patterns between the two tumor types.
bioRxiv · May 9, 2021Cancer Biology
K. Corbit, J. P. G. Camporez, J. L. Tran, C. G. Wilson, D. Lowe, S. Nordstrom, K. Ganeshan, R. J. Perry, G. Schulman, M. J. Jurczak, E. Weiss
This study shows that adipocyte Jak2 mediates GH-induced hepatic insulin resistance through an adipose-dependent mechanism.
bioRxiv · Sep 20, 2016Physiology